Latab, Nanie S.
HRN: 13-82-23 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/03/2023
CEFTAZIDIME 1GM (VIAL)
12/03/2023
12/10/2023
IV
1 Gram
Q8H
CAP MR; T/C TB Bronchiectasis
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: No